UNSPSC 51112801: Droloxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C26H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0M67U6Z98F, chemically known as phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)- but more generally known as droloxifene, which bears US NIH Compound Identifier 3033767. European Medicines Agency schedules Droloxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06405MIG.

UNSPSC 51112801 Droloxifene, a Commodity code, covers pharmaceutical active ingredients and finished pharmaceutical products procured by state and local health agencies. State and local governments buy under this code primarily through their health and human services departments and Medicaid programs to support prescription drug formularies, pharmacy benefit management, and direct-to-manufacturer procurement arrangements that aim to reduce pharmaceutical costs and improve prescription fulfillment efficiency. The issuing bodies soliciting under this code are predominantly state health and human services commissions and related state pharmacy benefit programs rather than counties, municipalities, school districts, or transit authorities, reflecting the concentration of pharmaceutical procurement at the state level where centralized formularies and benefit programs operate.

The Texas Health and Human Services Commission posted a Request for Information (RFI) in early April 2026 (HHS0017013, due April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program designed to establish direct relationships between the state pharmacy benefit program and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The RFI represents an exploratory phase intended to inform future formal solicitation strategy rather than a competitive procurement with binding timelines or award values. The source identifies activity in Texas; geographic spread across other states and additional recent opportunities under this code are not documented in the available record.